Together with these previous findings, our data nominate SOX2 and INSM1 mRNAs as critical targets of ZFP36L1 required for its ability to block neuroendocrine differentiation and SCLC proliferation. This evidence concerns the gene SOX2 and small cell lung carcinoma.